Sloane was born with a KIF1A mutation and is a special case at n-Lorem—she was the first patient to receive a medicine originally designed for someone else. Her mother, Megan, and grandfather, Tom, join the Patient Empowerment Program to share her journey and provide an update on how she’s doing six months after treatment.
On This Episode We Discuss:
Sloane’s KIF1A diagnosis
Nano-rare diseases affect the entire family
Sloane was able to use the same ASO as another KIF1A patient
Finding n-Lorem through KIF1A.ORG
Shocked that n-Lorem was able to create personalized treatments efficiently at cost
Sloane’s case is unique in a variety of ways and the decision to treat
How Sloane has responded to treatment
Are better measurements of benefit needed for nano-rare patients?
How Sloane has brought empathy, joy, and positivity to her family
Tom unretired to help fund research and support
The origins of ASO medicine is a long haul
Thank you to Hongene Biotech for sponsoring this patient story episode!
Make Hope Possible for nano-rare patients with a donation to n-Lorem.
Podden och tillhörande omslagsbild på den här sidan tillhör
n-Lorem Foundation (Dr. Stan Crooke, Amy Williford, Kim Butler, Andrew Serrano, Jon Magnuson, and Kira Dineen). Innehållet i podden är skapat av n-Lorem Foundation (Dr. Stan Crooke, Amy Williford, Kim Butler, Andrew Serrano, Jon Magnuson, and Kira Dineen) och inte av,
eller tillsammans med, Poddtoppen.